Siu LL - Search Results

1

Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.

Ringash J, Au HJ, Siu LL, Shapiro JD, Jonker DJ, Zalcberg JR, Moore MJ, Strickland A, Kotb R, Jeffery M, Alcindor T, Ng S, Salim M, Sabesan S, Easaw JC, Shannon J, El-Tahche F, Walters I, Tu D, O'Callaghan CJ; NCIC Clinical Trials Group; Australasian Gastrointestinal Trials Group. Ringash J, et al. Among authors: siu ll. Cancer. 2014 Jan 15;120(2):181-9. doi: 10.1002/cncr.28410. Epub 2013 Oct 11. Cancer. 2014. PMID: 24127364 Free article. Clinical Trial.

2

Other chemotherapy regimens including mitoxantrone and suramin.

Siu LL, Moore MJ. Siu LL, et al. Semin Urol Oncol. 1997 Feb;15(1):20-7. Semin Urol Oncol. 1997. PMID: 9050136 Review.

3

Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

Siu LL, Chapman W, Moore MJ. Siu LL, et al. Am J Clin Oncol. 1997 Dec;20(6):558-61. doi: 10.1097/00000421-199712000-00004. Am J Clin Oncol. 1997. PMID: 9391539

4

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks.

Siu LL, Oza AM, Eisenhauer EA, Firby PS, Thiessen JJ, Michael M, Wainman N, Manzo J, Feld R, Goldberg RA, Moore MJ. Siu LL, et al. J Clin Oncol. 1998 Mar;16(3):1122-30. doi: 10.1200/JCO.1998.16.3.1122. J Clin Oncol. 1998. PMID: 9508199 Clinical Trial.

5

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.

Siu LL, Banerjee D, Khurana RJ, Pan X, Pflueger R, Tannock IF, Moore MJ. Siu LL, et al. Clin Cancer Res. 1998 Mar;4(3):559-65. Clin Cancer Res. 1998. PMID: 9533522

6

Use of mesna to prevent ifosfamide-induced urotoxicity.

Siu LL, Moore MJ. Siu LL, et al. Support Care Cancer. 1998 Mar;6(2):144-54. doi: 10.1007/s005200050149. Support Care Cancer. 1998. PMID: 9540174 Review.

7

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.

Siu LL, Czaykowski PM, Tannock IF. Siu LL, et al. J Clin Oncol. 1998 Jul;16(7):2514-21. doi: 10.1200/JCO.1998.16.7.2514. J Clin Oncol. 1998. PMID: 9667272 Clinical Trial.

8

A phase II study of temozolomide in advanced untreated pancreatic cancer.

Moore MJ, Feld R, Hedley D, Oza A, Siu LL. Moore MJ, et al. Among authors: siu ll. Invest New Drugs. 1998;16(1):77-9. doi: 10.1023/a:1006043332368. Invest New Drugs. 1998. PMID: 9740547 Clinical Trial.

9

Telomerase: therapeutic potential in cancer.

Davis AJ, Siu LL. Davis AJ, et al. Among authors: siu ll. Cancer Invest. 2000;18(3):269-77. doi: 10.3109/07357900009031830. Cancer Invest. 2000. PMID: 10754994 Review. No abstract available.

10

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.

Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM. Patnaik A, et al. Among authors: siu ll. J Clin Oncol. 2000 Nov 1;18(21):3677-89. doi: 10.1200/JCO.2000.18.21.3677. J Clin Oncol. 2000. PMID: 11054441 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters